Skip to main content

Advertisement

SpringerLink
Log in

Invited commentary

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. IsraËl, L., Halpern, B.N.: LeCorynebacterium parvum dans les cancers avancés. Première évaluation de l'activité thérapeutique de cette immunostimuline. Nouv. Presse Med.1:19, 1972

    Google Scholar 

  2. Band, P.R., Jao-King, C., Urtasun, R., Haraphongse, M.: Phase I study ofCorynebacterium parvum in patients with solid tumors. Cancer Chemother. Rep.59:1139, 1975

    Google Scholar 

  3. Carter, S.K.: The current status of clinical immunotherapy as viewed at the 1976 AACR-ASCO meetings. Cancer Immunol. Immunother.1:275, 1976

    Google Scholar 

  4. Presant, C.A., Smalley, R.V., Vogler, W.R.: Cyclophosphamide (CTX) plus dimethyltriazeno imidazole carboxamide (DIC) with or withoutCorynebacterium parvum (CP) in metastatic malignant melanoma (MM). Proc. Am. Assoc. Cancer Res.17:241, 1976

    Google Scholar 

  5. Presant, C.A., Smalley, R.V., Vogler, W.R.: Therapy of metastatic malignant melanoma with cyclophosphamide plus DTIC with or withoutC. parvum (CP). Proc. Am. Assoc. Cancer Res.18:283, 1977

    Google Scholar 

  6. Bjornsson, S., Takita, H., Kuberka, N., Preisler, H.: Chemotherapy plus MER orC. parvum in advanced lung cancer. Proc. Am. Assoc. Cancer Res.18:294, 1977

    Google Scholar 

  7. Fisher, B., Rubin, H., Sartiano, G., Ennis, L., Wolmark, N.: Observations followingCorynebacterium parvum administration to patients with advanced malignancies. A phase I study. Cancer38:119, 1976

    Google Scholar 

  8. Lamoureux, G., Poisson, R., Desrosiers, M.: An antagonistic side effect of BCG immunotherapy: induction of immunological annergy. In BCG in Cancer Immunotherapy, G. Lamoureux, R. Turcotte, V. Portelance, editors. New York, Grune and Stratton, 1976

    Google Scholar 

  9. Kirchner, H., Glaser, M., Herberman, R.B.: Suppression of cell-mediated tumour immunity byCorynebacterium parvum. Nature257:396, 1975

    Google Scholar 

  10. Woodruff, M.F.A., Warner, N.L.: Effect ofCorynebacterium parvum on tumor growth in normal and athymic (nude) mice. J. Natl. Cancer Inst.58:111, 1977

    Google Scholar 

  11. Farquhar, D., Loo, T.L., Reed, R., Luna, M.:Corynebacterium parvum and anesthetics. Lancet1:914, 1975

    Google Scholar 

  12. Lipton, A., Hepner, G.W., Harvey, H.A.: Decreased hepatic drug demethylation in patients receiving BCG and chemoimmunotherapy. Proc. Am. Assoc. Cancer Res.18:276, 1972

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut du Cancer de Montréal, Centre Hospitalier Notre-Dame, Montréal, Canada

    Pierre R. Band M.D.

Authors
  1. Pierre R. Band M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Band, P.R. Invited commentary. World J. Surg. 1, 594–595 (1977). https://doi.org/10.1007/BF01556184

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01556184

Keywords

Search

Navigation